Colon Cancer

Colon cancer is a cancer that starts in the large intestine, also called the colon. It is different from rectal cancer, which begins in the rectum, although the two are often grouped together as colorectal cancer. Colon cancer may begin as a polyp, or abnormal growth, in the inner lining of the colon; some polyps can slowly become cancerous. It can affect people of different ages, including adults without a known family history or other obvious risk factors.

Colon cancer develops when accumulated changes in the DNA of colon cells cause them to grow and divide abnormally. In some cases, a precancerous polyp gradually acquires additional changes and becomes cancer; in others, cancer develops through a different pathway. These changes can be inherited or acquired during a person’s lifetime, and there is usually no single identifiable cause. A risk factor may increase the likelihood of cancer but is not the same as a direct cause.

Polyps and inherited gene changes

Some colon cancers arise from adenomatous or other precancerous polyps that are found and removed during screening. Inherited gene changes, such as those linked with Lynch syndrome or familial adenomatous polyposis, can make cancer more likely and may lead to earlier or more frequent screening. Lifestyle and medical factors, including diet, tobacco use, alcohol, inflammatory bowel disease, and excess body weight, may also raise risk, but they do not mean a person caused their cancer.

People without obvious risk factors can still develop colon cancer, so screening and attention to concerning symptoms remain important. Younger adults, including those wondering about colon cancer females symptoms, should discuss persistent bowel changes, bleeding, anemia, or a family history with a clinician rather than assuming age makes cancer impossible.

As colon cancer grows, it can cause bowel narrowing or obstruction, bleeding, iron-deficiency anemia, abdominal pain, or, less commonly, a hole in the bowel wall called perforation. Cancer can also spread to nearby lymph nodes or distant organs, such as the liver or lungs. Treatment effects vary: surgery may temporarily change bowel function or require an ostomy, while chemotherapy and other systemic treatments may cause fatigue, nausea, infection risk, hair changes, or nerve symptoms. Targeted therapy, immunotherapy, and radiation can have additional effects, including skin problems or immune-related inflammation when relevant.

Diagnosis usually begins with a medical history and examination, followed by tests chosen for the person’s symptoms and risk. Blood tests may check for anemia and overall health; tumor-marker blood tests may be used in selected situations but cannot diagnose colon cancer by themselves. Colonoscopy allows a clinician to examine the colon and take a biopsy, which is examined by a pathologist. CT or other imaging and additional tests help determine whether cancer has spread and support treatment planning.

The final stage is based on the surgical or biopsy pathology report together with imaging and other findings. Tumor testing can identify features that affect treatment choices, and a second opinion may help when decisions are complex. Stage describes the extent of disease, but it does not guarantee an individual outcome.

Treatment for colon cancer depends mainly on the stage of the disease, tumor characteristics, and the patient’s overall health.

Surgery

Surgery is the main treatment for many patients. It involves removing the tumor and nearby lymph nodes. In some cases, the ends of the colon are reconnected, while a temporary or permanent colostomy may be needed.

Chemotherapy

Chemotherapy may be used after surgery to reduce the risk of recurrence, especially in stage III or high-risk stage II disease. For advanced colon cancer, it can also help control the disease and relieve symptoms.

Targeted Therapy

Targeted therapies may be used for advanced colon cancer when the tumor has specific genetic characteristics, such as RAS or BRAF mutations. These treatments target specific molecules involved in cancer growth.

Immunotherapy

Immunotherapy can be effective in some patients whose tumors have specific features, such as mismatch repair deficiency (dMMR) or high microsatellite instability (MSI-H). It helps the immune system recognize and attack cancer cells.

Radiation Therapy

Radiation therapy is used less often for colon cancer than for rectal cancer. However, it may be considered in selected cases, particularly when the tumor cannot be completely removed or to relieve symptoms.

Treatment is selected individually according to the cancer stage, molecular test results, and the patient’s overall health.

Risk-reduction steps include not smoking, limiting alcohol, staying physically active, maintaining a healthy weight, and eating a balanced diet with adequate fiber. Managing inflammatory bowel disease and other relevant medical conditions with a clinician is also important. These measures may lower risk, but prevention cannot eliminate every possibility of colorectal cancer.

Screening options and timing

Earlier-stage colon cancer is often treated with curative intent, although ongoing follow-up is still needed. Advanced disease may require longer-term treatment and monitoring, and some people live for extended periods with disease control. The outlook varies widely, so a diagnosis or stage cannot by itself predict what will happen to one person.

Factors that affect prognosis

Prognosis is influenced by the stage, lymph-node involvement, distant spread, tumor biology, response to treatment, age, and overall health. Survival statistics are population estimates based on groups of people diagnosed in earlier periods; they may lag behind current treatments and cannot predict an individual’s outcome. A cancer team can explain how these factors apply to a particular case, including stage 4 colon cancer.

Follow-up commonly includes scheduled visits, colonoscopy, blood tests such as tumor-marker monitoring when appropriate, and imaging based on the person’s treatment and risk of recurrence. The timing varies by stage, treatment, test results, and overall health, so patients should follow their individualized care plan rather than a general schedule.

Monitoring for recurrence

Tell the care team about new bowel changes, bleeding, unexplained weight loss, persistent pain, or worsening fatigue. Survivorship care may also address bowel-function changes, ostomy care, nutrition, neuropathy, emotional health, work, sexual health, and fertility when relevant. Primary care and cancer specialists can coordinate preventive care and support a return to daily activities.